Expert Rev Vaccines. 2016 Jun 8. [Epub ahead of print]
To evaluate the impact of PCV7 and PCV13 on pneumococcal serotype distribution and penicillin-non-susceptibility in invasive infections in Kuwait.
Children < 2 y were given PCV7 from Aug 2006 to Jul 2010 (period I), and PCV13 from Aug 2010 to Jul 2013 (period II) with a pre-vaccination period from Aug 2003 to Jul 2006. Serotype and penicillin-non-susceptibility of blood and cerebrospinal fluid isolates from all ages were determined.
In <2 y old children, even with a small number of infections, a drop in PCV7 serotypes was evident after vaccination. For all age groups combined, in the pre-vaccination period, PCV7, PCV13, PCV13 non-PCV7 serotypes and penicillin-non-susceptibility constituted 53.2%, 72.6%, 19.4% and 6.5% of the isolates respectively. PCV7, PCV13 non-PCV7 serotypes and penicillin-non-susceptibility changed to 32.7%, 28.2% and 7.3% (period I) and 6.6%, 22.2% and 8.9% (period II).
Vaccines reduced invasive infections due to PCV7 serotypes.
Kuwait; Streptococcus pneumoniae; antibiotic resistance; invasive pneumococcal disease; pneumococcal conjugate vaccines; pneumococcal serotypes
PMID: 27267070 [PubMed - as supplied by publisher]